Stock data
Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. (CUE) reported revenue of US$27.47M and net income of -US$26.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$27.47M | — | -US$26.55M | -US$26.60M | — |
| 2024 | US$9.29M | — | -US$41.50M | -US$40.67M | — |
| 2023 | US$5.49M | — | -US$52.15M | -US$50.73M | — |
| 2022 | US$1.25M | — | -US$53.23M | -US$53.01M | — |
| 2021 | US$14.94M | — | -US$43.71M | -US$44.16M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$7.88M | -US$153.07M | — |
| 2026-03-31 | US$5.69M | -US$5.18M | — |
| 2025-12-31 | US$21.94M | US$1.58M | — |
| 2025-09-30 | US$2.15M | -US$7.45M | — |
| 2025-06-30 | US$2.95M | -US$8.48M | — |
| 2025-03-31 | US$0.42M | -US$12.26M | — |
| 2024-12-31 | US$1.58M | -US$9.50M | — |
| 2024-09-30 | US$3.34M | -US$8.66M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.